{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:11:09Z","timestamp":1783980669021,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Opioid dependence is commonly comorbid with depression and anxiety, which contribute to greater disability and poorer quality of life. This study assessed the prevalence of these comorbidities and their socio-demographic and clinical correlates in treatment-seeking individuals with opioid dependence in India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study at a tertiary care center in North India. A total of 255 adult patients diagnosed with opioid dependence (ICD-11) were recruited after fulfilling inclusion and exclusion criteria. Depression and anxiety were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7). Quality of life and disability were measured using the WHOQOL-BREF and WHODAS 2.0. Logistic regression was performed to examine predictors of moderate-to-severe depression (PHQ-9 \u226510) and anxiety (GAD-7 \u226510). Ethical approval was obtained from the Institutional Ethics Committee.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The participants had a median age of 28 (24-32) years; heroin was the predominant opioid (87%), and 30% reported injecting use. More than half (57%) had moderate-to-severe depression and 42% had moderate-to-severe anxiety, which were strongly correlated (r = 0.90). Both conditions were associated with higher disability and poorer quality of life across all domains. In univariate analyses, unemployment, stigma, interpersonal problems, and lack of abstinence were consistently linked with worse outcomes. Multivariable models showed that depression was independently predicted by stigma (OR = 2.95), interpersonal problems (OR = 4.21), and absence of opioid agonist treatment (OR = 0.30, protective). For anxiety, interpersonal problems were the strongest predictor (OR = 4.98), while past-month abstinence was protective (OR = 0.45).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings highlight the significant burden of depression and anxiety among individuals with opioid dependence, with significant implications for disability and quality of life. Future research should focus on stigma reduction, optimization of opioid agonist treatment, and integration of mental health care within addiction services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1708666","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:25:59Z","timestamp":1762323959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychosocial correlates of depression and anxiety among treatment-seeking individuals with opioid dependence: a cross-sectional study"],"prefix":"10.3389","volume":"16","author":[{"given":"Siddharth","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzafar","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvender Singh","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatan Pal Singh","family":"Balhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"B2","first-page":"1","volume-title":"Magnitude of substance use in India","author":"Ambekar","year":"2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and behavioral treatment of opioid use disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatr Res Clin Practice"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500286039","article-title":"The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)","volume":"24","author":"Ross","year":"2005","journal-title":"Drug Alcohol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis","volume":"238","author":"Santo","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5958\/2394-2061.2019.00030.2","article-title":"Study of sociodemographic correlates, anxiety, and depression among opioid dependents admitted in treatment centres in Sikkim, India","volume":"10","author":"Sharma","year":"2019","journal-title":"Open J Psychiatry Allied Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.21608\/amj.2022.212629","article-title":"A study of comorbidity between opioid addiction and major depressive disorders in El Hussein university hospital","volume":"51","author":"Mostafa Abd Allah","year":"2022","journal-title":"Al-Azhar Med J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnac029","article-title":"Mood and anxiety symptoms in persons taking prescription opioids: A systematic review with meta-analyses of longitudinal studies","volume":"23","author":"Leung","year":"2022","journal-title":"Pain Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12188","article-title":"Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study","volume":"24","author":"Griffin","year":"2015","journal-title":"Am J addictions"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/IJPSYM.IJPSYM_171_18","article-title":"Quality of Life and its Relationship with Perceived Stigma among Opioid Use Disorder Patients: An Exploratory Study","volume":"40","author":"Singh","year":"2018","journal-title":"Indian J Psychol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4103\/ijsp.ijsp_112_19","article-title":"A cross-sectional study to assess disability and internalized stigma among treatment-seeking individuals with opioid use disorders","volume":"36","author":"Dar","year":"2020","journal-title":"Indian J Soc Psychiatry"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: A review of the literature","volume":"21","author":"De Maeyer","year":"2010","journal-title":"Int J Drug policy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ejp.2163","article-title":"Socioeconomic risk factors for long-term opioid use: A national registry-linkage study","volume":"28","author":"Nestvold","year":"2024","journal-title":"Eur J Pain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Internal Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B16","volume-title":"Measuring health and disability: manual for WHO disability assessment schedule (WHODAS 20)","author":"\u00dcst\u00fcn","year":"2010"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","year":"1998","journal-title":"psychol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110829","article-title":"Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis","volume":"184","author":"Manea","year":"2012","journal-title":"Cmaj"},{"key":"B19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/15504263.2021.1979349","article-title":"Co-occurring opioid use and depressive disorders: patient characteristics and co-occurring health conditions","volume":"17","author":"Tormohlen","year":"2021","journal-title":"J dual diagnosis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1038\/s41598-023-45633-y","article-title":"Psychiatric comorbidities and concurrent substance use among people who inject drugs: a single-centre hospital-based study","volume":"13","author":"Kar","year":"2023","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13690-022-00940-0","article-title":"Quality of life and its correlated factors among patients with substance use disorders: a systematic review and meta-analysis","volume":"80","author":"Armoon","year":"2022","journal-title":"Arch Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1565624","DOI":"10.1080\/23311908.2019.1565624","article-title":"Predictors of quality of life of patients in opioid maintenance treatment in the first year in treatment","volume":"6","author":"Carlsen","year":"2019","journal-title":"Cogent Psychol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13011-020-00309-y","article-title":"Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway","volume":"15","author":"Aas","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13011-021-00417-3","article-title":"Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study","volume":"16","author":"Garpenhag","year":"2021","journal-title":"Subst Abuse treatment prevention policy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.janxdis.2009.08.010","article-title":"Predictors of social anxiety in an opioid dependent sample and a control sample","volume":"24","author":"Shand","year":"2010","journal-title":"J Anxiety Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/SAR.S304566","article-title":"The impact of stigma on people with opioid use disorder, opioid treatment, and policy","volume":"13","author":"Cheetham","year":"2022","journal-title":"Subst Abuse Rehabil"},{"key":"B27","doi-asserted-by":"publisher","first-page":"112469","DOI":"10.1016\/j.drugalcdep.2024.112469","article-title":"Psychometric performance of tools to measure internalized drug use stigma among people who use drugs and people on medication-assisted treatment in Dar es Salaam, Tanzania","volume":"264","author":"Endres-Dighe","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11790","DOI":"10.1038\/s41598-025-95967-y","article-title":"Associations between happiness with social factors and opioid agonist therapy among people who inject drugs","volume":"15","author":"Guerra","year":"2025","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281437","article-title":"Psychological distress and quality of life among Opioid Agonist Treatment service users with a history of injecting and non-injecting drug use: A cross-sectional study in Kathmandu, Nepal","volume":"18","author":"Pant","year":"2023","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-012-9753-z","article-title":"The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD","volume":"90","author":"Latkin","year":"2013","journal-title":"J Urban Health"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1708666\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:26:01Z","timestamp":1762323961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1708666\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":30,"alternative-id":["10.3389\/fpsyt.2025.1708666"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1708666","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1708666"}}